Rational design of indolyl acrylamides as antibacterial agents targeting multidrug-resistant Acinetobacter baumannii strains

Abstract

Antimicrobial resistance (AMR) has become a significant public health problem. This study investigated the structure-activity relationship of indole core molecules to uncover novel antimicrobials against resistant bacteria. Their antimicrobial evaluation against ESKAPEE bacteria showed superior efficacy compared to cefepime, meropenem, ciprofloxacin, and gentamicin against multidrug-resistant A. baumannii strain A-564, with minimum inhibitory concentration (MIC) values of 4.3 and 1.2 μg mL-1 for compounds 12e and 12j, respectively. Also, the same compounds showed better activity than cefepime for A. baumannii BAA ATCC 747 with MIC values of 1.2 and 4.4 μg mL-1. In addition, 12e and 12f showed activity against methicillin- and penicillin-resistant S. aureus with MIC of 3.2 and 2.1 μg mL-1. Furthermore, the highly active compounds 12e and 12j exhibited low toxicity, with hemolysis values >40 μg mL-1. Preliminary examination of the mechanism of action revealed that 12e could have a dose-dependent inhibition of the AbFtsZ1-412 enzyme from strain XDR A-564, obtaining a 51% inhibition of GTPase activity at 32 μg mL-1, thus altering the binary fission process, which could be attributed to the fact that 12e binds to the GTP site and interferes with the function of the enzyme by inhibiting the formation of the Z-ring. Also, a cell viability assay indicates that cells treated with these compounds showed increased permeability, compromising the stability of the A. baumannii A-564 membrane. These results provided valuable information for further developing indolyl-acrylamides as new antimicrobial agents.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Research Article
Submitted
14 Feb 2025
Accepted
12 May 2025
First published
20 May 2025
This article is Open Access
Creative Commons BY-NC license

RSC Med. Chem., 2025, Accepted Manuscript

Rational design of indolyl acrylamides as antibacterial agents targeting multidrug-resistant Acinetobacter baumannii strains

V. G. Domínguez Méndez, R. Ma. Chávez Santos, K. Carrillo-Jaimes, A. Hernández-Santoyo, S. Ramírez-Carreto, A. Hernandez-Garcia, R. Aguayo-Ortiz, C. D. Ceapa, J. Rivera-Chávez and R. Martinez, RSC Med. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5MD00145E

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements